Fundz

Ketoswiss Raises $4.8M To Drive Development Of Migraine Fighting Food

PRIVATEAug 08, 2023

Amount Raised

$4.8 Million

Round Type

Seed

BaselBiotechnologyHealth Care

Description

Ever heard the expression ‘feed a migraine, starve a fever’? No, neither have we, but food as a solution to migraine relief is exactly what Basel-based biotech start-up KetoSwiss is all about. Its product MigraKet, is a ‘dietary-preventive therapy’ which it says is ‘offering a clinically tested and patent-protected solution’ to your migraine issues

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as KetoSwiss that raised within 45 days of this round, from Fundz verified event records.

  • CMR Surgical raised $165M (Funding Round) on September 22, 2023.
  • Avalyn raised $189M on September 22, 2023.
  • CMR Surgical raised $165M (Funding Round) on September 21, 2023.
  • Streamex Corp. raised $1.2M (Seed) on September 21, 2023.
  • ReCode Therapeutics raised an undisclosed amount (Series B) on September 19, 2023.
  • BrainScope raised an undisclosed amount on September 19, 2023.

Who to call at KetoSwiss, and when

A new round usually means KetoSwiss is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day KetoSwiss raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at KetoSwiss, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at KetoSwiss. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

KetoSwiss

Location

Basel, Basel City, Switzerland

About

KetoSwiss is a Swiss biotechnology company located in Basel, that develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolic dysfunction (such as Alzheimer's disease). The lead product’s active substance is an endogenous metabolite – a Ketone body, that can be used by the human brain as an alternative source of fuel to glucose, when glucose utilization or transport is compromised.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment KetoSwiss raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for KetoSwiss's next move

See what Strategic adds

KetoSwiss raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.